Two Dozen-Plus Biotechs Went Public This Year—With More In The Works

Forbes - Business ·
Business Corporate
Business & Economy

In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.

Read original article on Forbes - Business →

Related news